43 related articles for article (PubMed ID: 26564640)
1. [Research on the association between U2-dependent spliceosome gene and hepatocellular cancer].
Song W; Zhu B; Tian Y; Zhong R; Tian J; Miao X; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Jun; 36(6):634-8. PubMed ID: 26564640
[TBL] [Abstract][Full Text] [Related]
2. SF3A1 and pancreatic cancer: new evidence for the association of the spliceosome and cancer.
Tian J; Liu Y; Zhu B; Tian Y; Zhong R; Chen W; Lu X; Zou L; Shen N; Qian J; Li H; Miao X; Wang L
Oncotarget; 2015 Nov; 6(35):37750-7. PubMed ID: 26498691
[TBL] [Abstract][Full Text] [Related]
3. [Association between pancreatic cancer risk and the interaction of U2AF65 gene polymorphisms and smoking].
Tian J; Zhu B; Tian Y; Zhong R; Miao X; Wang L
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Jun; 35(6):710-3. PubMed ID: 25174478
[TBL] [Abstract][Full Text] [Related]
4. The Associations between RNA Splicing Complex Gene SF3A1 Polymorphisms and Colorectal Cancer Risk in a Chinese Population.
Chen X; Du H; Liu B; Zou L; Chen W; Yang Y; Zhu Y; Gong Y; Tian J; Li F; Zhong S
PLoS One; 2015; 10(6):e0130377. PubMed ID: 26079486
[TBL] [Abstract][Full Text] [Related]
5. Association of genetic polymorphisms in STAT1 gene with increased risk of hepatocellular carcinoma.
Zhu ZZ; Di JZ; Gu WY; Cong WM; Gawron A; Wang Y; Zheng Q; Wang AZ; Zhu G; Zhang P; Hou L
Oncology; 2010; 78(5-6):382-8. PubMed ID: 20798561
[TBL] [Abstract][Full Text] [Related]
6. The MTHFR C677T mutation is not a risk factor recognized for HBV-related HCC in a population with a high prevalence of this genetic marker.
Jiao X; Luo Y; Yang B; Jing L; Li Y; Liu C; Jing X; Wang F; Wang Y; Du Z; Gao Y
Infect Genet Evol; 2017 Apr; 49():66-72. PubMed ID: 28082187
[TBL] [Abstract][Full Text] [Related]
7. Polymorphisms of the CYP1B1 gene and hepatocellular carcinoma risk in a Chinese population.
Liu F; Luo LM; Wei YG; Li B; Wang WT; Wen TF; Yang JY; Xu MQ; Yan LN
Gene; 2015 Jun; 564(1):14-20. PubMed ID: 25796598
[TBL] [Abstract][Full Text] [Related]
8. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
Akkiz H; Sümbül AT; Bayram S; Bekar A; Akgöllü E
Cancer Epidemiol; 2010 Aug; 34(4):448-52. PubMed ID: 20447891
[TBL] [Abstract][Full Text] [Related]
9. Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.
Nan YL; Hu YL; Liu ZK; Duan FF; Xu Y; Li S; Li T; Chen DF; Zeng XY
World J Gastroenterol; 2016 Jun; 22(24):5558-67. PubMed ID: 27350734
[TBL] [Abstract][Full Text] [Related]
10. Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.
Zhang QX; Li SL; Yao YQ; Li TJ
Int J Immunogenet; 2016 Jun; 43(3):151-8. PubMed ID: 27122304
[TBL] [Abstract][Full Text] [Related]
11. Interaction between p53 codon 72 and MDM2 309T>G polymorphisms and the risk of hepatocellular carcinoma.
Qiu M; Liu Y; Yu X; Qin L; Bei C; Zeng X; Qiu X; Tang B; He S; Yu H
Tumour Biol; 2016 Mar; 37(3):3863-70. PubMed ID: 26476535
[TBL] [Abstract][Full Text] [Related]
12. [Study on the relationship between single-nucleotide polymorphisms in IL-6, IL-10 genes and HBV-related hepatocellular carcinoma].
Qiu XQ; Bei CH; Yu HP; Zeng XY; Zhong QA
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 May; 32(5):510-3. PubMed ID: 21569738
[TBL] [Abstract][Full Text] [Related]
13. Association of intercellular adhesion molecule-1 single nucleotide polymorphisms with hepatocellular carcinoma susceptibility and clinicopathologic development.
Chen TP; Lee HL; Huang YH; Hsieh MJ; Chiang WL; Kuo WH; Chou MC; Yang SF; Yeh CB
Tumour Biol; 2016 Feb; 37(2):2067-74. PubMed ID: 26341495
[TBL] [Abstract][Full Text] [Related]
14. Association Between a Variant in ADAMTS5 and the Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population.
Li C; Xiong Y; Zhong Z; Zhang S; Peng Y; Wang L; Dai N; Li M; Ren T; Gan L; Wang D
Cell Biochem Biophys; 2015 May; 72(1):221-5. PubMed ID: 25519309
[TBL] [Abstract][Full Text] [Related]
15. Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case-control study in a high-risk region of China.
Chen X; Wang H; Xie W; Liang R; Wei Z; Zhi L; Zhang X; Hao B; Zhong S; Zhou G; Zhang L; Gao X; Zhu Y; He F
Pharmacogenet Genomics; 2006 Mar; 16(3):219-27. PubMed ID: 16495781
[TBL] [Abstract][Full Text] [Related]
16. Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.
Wang XH; Wang FR; Tang YF; Zou HZ; Zhao YQ
Genet Mol Res; 2014 Jul; 13(3):5048-54. PubMed ID: 25061729
[TBL] [Abstract][Full Text] [Related]
17. [Interaction between the single-nucleotide polymorphism of DNA repair gene hOGG1 and HBV infection and its susceptibility to hepatocellular carcinoma].
Ji L; Zeng X; Li L; Qiu X; Chen S; Yu H
Wei Sheng Yan Jiu; 2011 Nov; 40(6):705-8. PubMed ID: 22279661
[TBL] [Abstract][Full Text] [Related]
18. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the VEGFA promoter are associated with susceptibility to hepatocellular carcinoma by altering promoter activity.
Wu X; Xin Z; Zhang W; Wu J; Chen K; Wang H; Zhu X; Pan L; Li Z; Li H; Liu Y
Int J Cancer; 2013 Sep; 133(5):1085-93. PubMed ID: 23404364
[TBL] [Abstract][Full Text] [Related]
20. Association between a single nucleotide polymorphism of the XRCC1 gene and hepatocellular carcinoma susceptibility in the Chinese Han population.
Li XF; Chen YX; Ye WW; Tao XF; Zhu JH; Wu S; Lou LQ
Genet Mol Res; 2014 Jan; 13(1):160-6. PubMed ID: 24446299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
